Skip to main content

Table 2 Summary of the inclusion and exclusion criteria at screening

From: Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania

Inclusion criteria

Exclusion criteria

Hemoglobin SS genotype

Chronic transfusion program as defined by participating in a scheduled (pre-planned) series of transfusions for prophylactic purposes or a hemoglobin A level >20 % of the total hemoglobin

Age ≥18 years and living in Dar es Salaam

Haemoglobin <4.0 g/dL

Male or female (post-menopausal, sterile, or using an acceptable method of contraception)

HIV positive

Negative urine pregnancy test at Screening and a negative urine pregnancy test (dipstick) prior to randomization and dosing

Female planning to become pregnant during the study period

Absolute neutrophil count >1500/uL

Serious mental (including psychosis) or physical illness, which, in the opinion of the investigators would compromise participation in the study (e.g. impaired mental capacity, alcoholism)

Platelet count >95,000/uL

Any condition which the investigators judge to preclude safe participation in the study or to confound the evaluation of the study outcome

Serum creatinine <100 μmol/L (1.2 mg/dL)

 

Alanine transaminase less than two times the upper limit of normal

 

Being able and willing to record and submit videos electronically.